丸生殖细胞瘤发生的潜在治疗标和生物标志物
Francesco Esposito1,2, Marco De Martino2, Viviana Franco1,3
1Istituto degli Endotipi in Oncologia, Metabolismo e Immunologia "G. Salvatore" del CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Scuola di Medicina e Chirurgia di Napoli, Università degli Studi di Napoli 'Federico II', Naples, Italy.
Expert opinion on therapeutic targets
|August 21, 2025
概括
在全球范围内,丸生殖细胞瘤 (TGCT) 正在增加. 新的分子标和生物标志物为改善治疗和诊断提供了希望,
科学领域:
- 癌症学
- 分子生物学
- 遗传学
背景情况:
- 丸生殖细胞瘤 (TGCT) 是年轻成年男性中最常见的固体癌症.
- 全球TGCT发病率的增加需要新的治疗策略.
- 在大约20%的转移性TGCT患者中出现基斯普拉丁基化疗耐药性.
研究的目的:
- 审查TGCT病理生理学和治疗的最新进展.
- 突出TGCT管理的新兴分子目标和生物标志物.
- 讨论精准医学在改善TGCT结果方面的潜力.
主要方法:
- 对TGCT分子驱动剂和治疗剂的当前文献的审查.
- 用于诊断和监测的新生物标志物的分析.
- 讨论TGCT治疗的挑战和未来方向.
主要成果:
- 主要的致癌驱动因素包括氨酸激酶受体,转录因子,DNA损伤反应元素和细胞循环调节剂.
- 有前途的早期药物包括CDK抑制剂,PARP抑制剂和Aurora激酶抗剂.
- 生物标志物如CLDN6,cfDNA/ctDNA和miR-371373集群使无创性液体活检能够提高疾病的评估.
结论:
- 分子分析和生物标志物驱动的方法为TGCT准确医学铺平了道路.
- 临床验证,患者选择和标准化对于实施新策略至关重要.
- 针对性治疗和分子诊断的整合有望提高TGCT治疗的生存率和降低毒性.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K


